ETCM
Evolutionary Tree Capital Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Sell |
18,454
-2,202
| -11% | -$380K | 3.38% | 14 |
|
|
2025
Q1 | $3.22M | Sell |
20,656
-9,459
| -31% | -$1.47M | 3.74% | 12 |
|
|
2024
Q4 | $4.15M | Sell |
30,115
-2,638
| -8% | -$363K | 4.22% | 8 |
|
|
2024
Q3 | $4.89M | Buy |
32,753
+7,891
| +32% | +$1.18M | 4.9% | 6 |
|
|
2024
Q2 | $3.39M | Buy |
24,862
+11,223
| +82% | +$1.53M | 3.49% | 9 |
|
|
2024
Q1 | $2.06M | Sell |
13,639
-3,087
| -18% | -$467K | 2.08% | 25 |
|
|
2023
Q4 | $2.11M | Buy |
16,726
+69
| +0.4% | +$8.69K | 2.33% | 15 |
|
|
2023
Q3 | $1.56M | Sell |
16,657
-290
| -2% | -$27.2K | 2.01% | 20 |
|
|
2023
Q2 | $1.51M | Buy |
16,947
+6,295
| +59% | +$562K | 1.82% | 19 |
|
|
2023
Q1 | $1.14M | Sell |
10,652
-11,695
| -52% | -$1.25M | 1.58% | 22 |
|
|
2022
Q4 | $2.73M | Sell |
22,347
-6,799
| -23% | -$830K | 2.62% | 15 |
|
|
2022
Q3 | $3.01M | Buy |
29,146
+6,487
| +29% | +$670K | 2.89% | 14 |
|
|
2022
Q2 | $2.11M | Sell |
22,659
-14,842
| -40% | -$1.38M | 2.29% | 21 |
|
|
2022
Q1 | $4.4M | Sell |
37,501
-5,211
| -12% | -$612K | 3.06% | 12 |
|
|
2021
Q4 | $5.75M | Buy |
42,712
+19,470
| +84% | +$2.62M | 2.76% | 20 |
|
|
2021
Q3 | $3.71M | Buy |
23,242
+5,872
| +34% | +$936K | 1.64% | 28 |
|
|
2021
Q2 | $2.29M | Buy |
17,370
+606
| +4% | +$79.7K | 1.05% | 33 |
|
|
2021
Q1 | $2.16M | Buy |
16,764
+4,552
| +37% | +$587K | 1.28% | 30 |
|
|
2020
Q4 | $2.04M | Buy |
+12,212
| New | +$2.04M | 1.55% | 27 |
|